Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
7.545
+0.095 (+1.28%)
Streaming Delayed Price
Updated: 12:40 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Goodrx Holdings Inc Cl A
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript
November 08, 2022
GDRX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
GoodRx Reports Third Quarter 2022 Results
November 08, 2022
From
GoodRx Holdings, Inc.
Via
Business Wire
Where GoodRx Holdings Stands With Analysts
November 04, 2022
Over the past 3 months, 10 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
10 Analysts Have This to Say About GoodRx Holdings
November 04, 2022
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings:
Via
Benzinga
New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe
November 03, 2022
From
GoodRx
Via
Business Wire
Expert Ratings for GoodRx Holdings
October 11, 2022
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 13 Analyst Ratings Have To Say About GoodRx Holdings
August 09, 2022
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Upgrades
Via
Benzinga
GoodRx to Present at Upcoming Investor Conferences
October 27, 2022
From
GoodRx Holdings, Inc.
Via
Business Wire
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022?
October 16, 2022
These four tech stocks are down nearly 90%.
Via
The Motley Fool
Before Pushing Others At Work, Take A Look In The Mirror
October 14, 2022
Leaders often see their job as driving greatness from others. But the first step is developing your own leadership style.
Via
Investor's Business Daily
GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers
October 13, 2022
From
GoodRx
Via
Business Wire
GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®
October 13, 2022
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call
October 11, 2022
From
GoodRx Holdings Inc.
Via
Business Wire
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's
October 11, 2022
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69...
Via
Benzinga
Where GoodRx Holdings Stands With Analysts
October 11, 2022
Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
GoodRx Offers Free Telehealth Appointments to Florida Residents Affected by Hurricane Ian
October 04, 2022
From
GoodRx
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
September 16, 2022
Via
Benzinga
What 14 Analyst Ratings Have To Say About GoodRx Holdings
September 07, 2022
Over the past 3 months, 14 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference
August 29, 2022
From
GoodRx Holdings, Inc.
Via
Business Wire
Looking Into GoodRx Holdings's Return On Capital Employed
August 29, 2022
GoodRx Holdings (NASDAQ:GDRX) brought in sales totaling $191.80 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 111.51%, resulting in a loss of $1.42 million.
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Gainers
Via
Benzinga
GoodRx Holdings, Inc. (NASDAQ: GDRX) Investor Alert: Investigation over Potential Wrongdoing
August 15, 2022
San Diego, CA -- (SBWIRE) -- 08/15/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at GoodRx Holdings, Inc.
Via
SBWire
The Most Expensive Drug From Novartis Associated With Two Deaths: Report
August 12, 2022
Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE: NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
Via
Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
August 10, 2022
OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
August 09, 2022
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 09, 2022
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.